Q3 European Medtech Deals Up Nearly 13%
During Q3 2019, the medtech sector in Europe experienced an uptick in deal activity. Transactions were up 12.7% compared to the four-quarter average and were worth $627.42 million, according to GlobalData. Within those 80 deals are the following highlights:
- Venture financing = 40 transactions (50%), valued at $539 million
- M&A = 29 deals (36%), valued at $80 million
- Private equity deals = 11 (14%), valued at $7.8 million
- Top 5 deals
- CMR Surgical: $242.7 million venture financing
- Quanta Dialysis Technologies: $47 million venture financing
- iSTAR Medical: $44 million venture financing
- Cytena: $33.6 million acquisition by Cellink
- RAL Diagnostics: $27.9 million acquisition by CellaVision
Related Articles
-
It is more important than ever for medical manufacturers to prepare for business interruption due to unexpected damage or natural disasters. From building a recovery team to securing proper insurance, there are many steps device manufacturers can take to recover…
-
Nondisclosure agreements (NDAs) can help protect trade secrets and build a framework for better cooperation and understanding between parties. Following are some key areas to consider when creating an NDA.
-
Veeva Vault CRM for Medtech is a unified customer relationship management (CRM) and content management application built for medtech sales teams, key account managers and medical affairs professionals.
-
Balwani was found guilty on 10 counts of wire fraud and two counts of conspiracy to commit wire fraud for misleading investors about the financial health of the healthcare startup. He faced up to 20 years in prison for each…
